Neogen Chemicals

NEOGENCHEMICALS26 Apr 2024

Chemicals

₹

-50.25 (-3.23%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Neogen Chemicals

Neogen Chemicals

Chemicals

NEOGENCHEMICALS26 Apr 2024

₹

-50.25 (-3.23%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
13-May-2023	D	Recommended a final dividend of Rs. 3 per Equity Share for the Financial Year 2022-23, subject to approval of shareholders at the ensuing Annual General Meeting of the Company.	25-Aug-2023
14-May-2022	D	Recommended a final dividend of Rs. 2.75 per Equity Share for the Financial Year 2021-22, subject to approval of shareholders at the ensuing General Meeting of the Company.	19-Sep-2022
31-May-2021	D	Neogen Chemicals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2021, inter alia, has recommended a final dividend of Rs. 2.25 per Equity Share for the Financial Year 2020-21, subject to approval of Shareholders at the ensuing Annual General Meeting of the Company.	16-Sep-2021
23-May-2020	D	The meeting of the Board of Directors of the Company which commenced at 3.00 P.M and concluded at 11.35 P.M. today i.e. May 23, 2020, the following decisions were taken: Recommendation of a final dividend of Rs. 2/- per Equity Share for the FY 2019-20, subject to approval of Shareholders at the ensuing Annual General Meeting of the Company.	17-Sep-2020
27-May-2019	D	Recommendation of dividend of Rs. 1.50/- per Equity Share for the Financial Year 2018-19, subject to approval of Shareholders at the ensuing Annual General Meeting of the Company.	11-Sep-2019
24-Apr-2024	BC	Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2024 inter alia to consider and approve Pursuant to regulation 29 and 33 of the Li	30-Apr-2024
01-Feb-2024	BC	Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve Pursuant to regulation 29 and 33 of the SE	09-Feb-2024
23-Nov-2023	BC	Trading members of the Exchange are hereby informed that the under mentioned new securities of Neogen Chemicals Limited (Scrip Code - 542665) are listed and permitted to trade on the Exchange with ef	24-Nov-2023
01-Nov-2023	BC	Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve Pursuant to regulation 29 and 33 of the SE	08-Nov-2023
07-Nov-2023	BC	SBI Mutual Fund	01-Nov-2023

No Rights has been declared by NEOGENCHEMICALS

Book Closure

Record Date	Split Date	Purpose
30-Apr-2024	-	Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2024 inter alia to consider and approve Pursuant to regulation 29 and 33 of the Li
09-Feb-2024	-	Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve Pursuant to regulation 29 and 33 of the SE
24-Nov-2023	-	Trading members of the Exchange are hereby informed that the under mentioned new securities of Neogen Chemicals Limited (Scrip Code - 542665) are listed and permitted to trade on the Exchange with ef
08-Nov-2023	-	Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve Pursuant to regulation 29 and 33 of the SE
01-Nov-2023	-	SBI Mutual Fund

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Neogen Chemicals Ltd ₹1,507.50(-50.25/-3.23%)	1,507.50	-50.25	3,977.04	-6.00	97.54	5.29
Jubilant Industries Ltd ₹1,184.50(-14.65/-1.22%)	1,184.50	-14.65	1,784.70	194.10	0.00	5.84
Linde India Ltd ₹8,346.35(-43.65/-0.52%)	8,346.35	-43.65	71,177.67	111.19	169.31	22.15
Bodal Chemicals Ltd ₹79.40(-0.55/-0.69%)	79.40	-0.55	998.77	14.41	203.49	0.89
Gujarat Alkalies & Chemicals Ltd ₹805.55(+2.05/0.26%)	805.55	+2.05	5,915.96	9.82	0.00	0.95
Omkar Speciality Chemicals Ltd ₹7.20(0.00/0.00%)	7.20	+0.00	14.82	-2.70	0.00	-0.09

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	167.37	168.24	170.12	203.92	186.25	148.12
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	167.37	168.24	170.12	203.92	186.25	148.12
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	1.48	1.87	1.84	1.77	1.40	0.50
Total Income	168.85	170.11	171.96	205.69	187.65	148.62
Total Expenditure	141.60	142.00	140.67	171.33	156.11	123.87
PBIDT	27.25	28.11	31.29	34.36	31.54	24.75
Interest	10.03	10.75	10.61	9.34	6.66	6.86
PBDT	17.22	17.36	20.68	25.02	24.88	17.89
Depreciation	5.00	4.93	4.92	4.29	4.14	3.88
Tax	3.19	1.62	3.40	3.53	3.85	1.67
Deferred Tax	3.23	1.67	0.94	2.87	2.18	2.45
Reported Profit After Tax	5.80	9.14	11.42	14.33	14.71	9.89
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	5.80	9.14	11.42	14.33	14.71	9.89

EPS (Unit Curr.)	2.24	3.66	4.58	5.76	5.89	3.96
EPS (Adj) (Unit Curr.)	2.24	3.66	4.58	5.76	5.89	3.96
Calculated EPS (Unit Curr.)	2.20	3.66	4.58	5.75	5.90	3.97
Calculated EPS (Adj) (Unit Curr.)	2.20	3.66	4.58	5.75	5.90	3.97
Calculated EPS (Ann.) (Unit Curr.)	8.79	14.66	18.32	22.98	23.59	15.86
Calculated EPS (Adj) (Ann.) (Unit Curr.)	8.79	14.66	18.32	22.98	23.59	15.86
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	26.38	24.94	24.94	24.94	24.94	24.94
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	16.28	16.71	18.39	16.85	16.93	16.71
PBDTM(%)	10.29	10.32	12.16	12.27	13.36	12.08
PATM(%)	3.47	5.43	6.71	7.03	7.90	6.68

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	164.44	161.71	164.88	203.92	186.25	148.12
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	164.44	161.71	164.88	203.92	186.25	148.12
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	1.67	1.94	1.81	1.75	1.40	0.48
Total Income	166.11	163.65	166.69	205.67	187.65	148.60
Total Expenditure	144.15	135.79	136.82	171.33	156.13	123.87
PBIDT	21.96	27.86	29.87	34.34	31.52	24.73
Interest	10.52	11.09	10.76	9.34	6.66	6.86
PBDT	11.44	16.77	19.11	25.00	24.86	17.87
Depreciation	5.74	5.79	5.48	4.29	4.14	3.88
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	3.19	1.62	3.40	3.53	3.85	1.67
Deferred Tax	1.45	1.44	0.48	2.87	2.18	2.45
Reported Profit After Tax	1.06	7.92	9.75	14.31	14.69	9.87
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	1.06	7.92	9.75	14.31	14.69	9.87

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	1.06	7.92	9.75	14.31	14.69	9.87

EPS (Unit Curr.)	0.41	3.17	3.90	5.74	5.89	3.95
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	26.38	24.94	24.94	24.94	24.94	23.33

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	13.35	17.23	18.12	16.84	16.92	16.70
PBDTM(%)	6.96	10.37	11.59	12.26	13.35	12.06
PATM(%)	0.64	4.90	5.91	7.02	7.89	6.66

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	24.94	24.94	23.33	23.33	31.83	33.39
Reserves Total	457.67	414.38	159.79	133.40	50.38	30.58
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	482.61	439.32	183.12	156.73	82.21	63.97
Secured Loans	362.21	224.73	216.00	137.12	107.14	43.72
Unsecured Loans	7.30	4.02	5.74	0.00	1.10	25.10
Total Debt	369.51	228.75	221.74	137.12	108.24	68.82
Total Liabilities	852.12	668.07	404.86	293.85	190.45	132.79
APPLICATION OF FUNDS :
Gross Block	389.66	313.41	143.51	119.06	87.51	68.90
Less : Accumulated Depreciation	42.21	28.28	16.80	8.52	4.69	1.85
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	347.45	285.13	126.71	110.54	82.82	67.05
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	35.84	10.62	114.65	2.69	0.39	1.38
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	76.51	81.21	0.45	0.45	0.45	0.45
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	292.97	194.59	114.03	129.87	72.38	49.99
Sundry Debtors	177.38	109.50	78.55	75.23	60.66	41.36
Cash and Bank	20.70	45.22	1.21	1.48	2.02	1.82
Loans and Advances	89.12	62.99	46.78	25.11	25.03	13.73
Total Current Assets	580.17	412.30	240.57	231.69	160.08	106.90
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	170.51	110.86	72.90	41.66	46.24	39.14
Provisions	3.84	2.13	1.12	1.45	1.10	0.70
Total Current Liabilities	174.35	112.99	74.02	43.10	47.34	39.84
Net Current Assets	405.82	299.31	166.55	188.59	112.74	67.06
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	9.09	10.48	1.46	0.81	1.17	1.67
Deferred Tax Liability	28.11	21.09	9.62	6.42	6.04	5.70
Net Deferred Tax	-19.02	-10.61	-8.16	-5.61	-4.87	-4.03
Total Assets	846.60	665.66	400.20	296.66	191.53	131.91
Contingent Liabilities	12.52	20.63	12.85	2.04	8.18	4.48

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	24.94	24.94	23.33	23.33	31.83	33.39
Reserves Total	457.58	414.30	159.68	132.91	50.12	30.42
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	482.52	439.24	183.01	156.24	81.95	63.81
Minority Interest	0.00	0.00	0.00	0.00	0.00	0.00
Secured Loans	362.21	224.73	216.00	137.12	107.14	43.72
Unsecured Loans	7.30	4.02	5.74	0.00	1.10	25.10
Total Debt	369.51	228.75	221.74	137.12	108.24	68.82
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	8.41	7.84	5.03	12.76	4.02	3.90
Total Liabilities	860.44	675.83	409.78	306.12	194.21	136.53
APPLICATION OF FUNDS :
Gross Block	389.66	313.41	143.51	120.45	87.51	68.90
Less: Accumulated Depreciation	42.21	28.28	16.80	9.91	4.69	1.85
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	347.45	285.13	126.71	110.54	82.82	67.05
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	35.84	10.62	114.65	2.69	0.39	1.38
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	76.81	81.73	0.75	0.60	0.53	0.42
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	292.97	194.59	114.03	129.87	72.38	49.99
Sundry Debtors	177.38	109.50	78.55	75.23	60.66	41.36
Cash and Bank	20.70	45.22	1.21	1.48	2.02	1.82
Loans and Advances	88.72	62.39	46.37	24.47	24.70	13.60
Total Current Assets	579.77	411.70	240.16	231.06	159.76	106.77
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	170.50	110.86	72.90	41.66	46.25	39.15
Provisions	3.84	2.13	1.12	1.45	1.10	0.70
Total Current Liabilities	174.34	112.99	74.02	43.10	47.35	39.85
Net Current Assets	405.43	298.71	166.14	187.95	112.41	66.92
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	9.09	10.48	1.46	0.81	1.17	1.67
Deferred Tax Liability	28.11	21.09	9.62	6.42	6.04	5.70
Net Deferred Tax	-19.02	-10.61	-8.16	-5.61	-4.87	-4.03
Other Assets	13.93	10.25	9.69	9.95	2.94	4.79
Total Assets
Contingent Liabilities	12.52	20.63	12.85	2.04	8.34	4.48

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	45.22	1.21	1.48	2.02	1.82
Net Cash from Operating Activities	-30.35	1.20	83.29	-34.12	-3.78
Net Cash Used In Investing Activities	-94.46	-145.62	-134.29	-28.88	-20.18
Net Cash Used In Financing Activities	100.29	188.43	50.73	62.46	24.16
Net Inc./Dec In Cash And Cash Equivalents	-24.52	44.01	-0.27	-0.54	0.20
Cash And Cash Equivalents At End Of The Year	20.70	45.22	1.21	1.48	2.02

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

56.89%

FII Shareholding

4.56%

DII Shareholding

22.14%

Public Shareholding

16.41%

**Promoter pledged shareholding 56.89%

About Neogen Chemicals Ltd

Neogen Chemicals Ltd is in the Chemicals sector, having a market capitalization of Rs. 3967.8 crores. It has reported a sales of Rs. 167.37 crores and a net profit of Rs. 5.8 crores for the quarter ended December 2018. The company management includes Haridas Thakarshi Kanani, Haridas Thakarshi Kanani,Harin Haridas Kanani,Anurag Surana,Sanjay N Mehta,HITESH BHARATKUMAR RESHAMWALA,Shyamsundar Radheshyam Upadhyay,Ranjan Kumar Malik,Avi Kersi Sabavala,Unnati Kanani (Neogen Chemicals Ltd) among others.

Chairman

Haridas Thakarshi Kanani

Registered office

1002 10th Flr Opp Cadbury Junc,Dev Corpora Bldg Off Pok RdNo2,Thane,Maharashtra,400601

FAX :91-22-2549 7399

Background

Incorporation Year1989

Face Value₹10

Market Lot1

How to buy Neogen Chemicals shares on nse?

To buy Neogen Chemicals shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Neogen Chemicals share price today?

The Neogen Chemicals shares price on nse is Rs.1507.5 today.

What is the market cap of Neogen Chemicals shares on NSE ?

The company has a market capitalization of Rs.3977.04Cr

What is the PE & PB ratio of Neogen Chemicals shares ?

PE is 97.54 and PB is 5.29

What is the 52 Week High and Low of Neogen Chemicals shares?

Neogen Chemicals stock price high: Rs.1859.3 Neogen Chemicals stock price low: Rs.1176